Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02904213Completed
Open-label, single-arm trial of Unifive in diphtheria, Tetanus, pertussis and 2 more. Primary endpoints: Immediate Adverse Events, Solicited Adverse Events and 2 more. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02904213.